Skip to main content
Caplight Logo









Neoplants

Neoplants

Private
ParisHealthcare & Life Scienceshttps://neoplants.com/

Last Round

Seed

Oct 27, 2022

Total Funding Raised

$20M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Neoplants is a biotechnology company that develops bioengineered plants and their microbiomes to purify indoor air by metabolizing volatile organic compounds (VOCs).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Home & Lifestyle

Business Model

B2C

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Keywords

synbiosynthetic biologybioengineered plantsair purificationindoor air qualitynatural air purifierair purifying plantsdirect-to-consumerVOC removalD2Csubscription commercebioengineered microbiomedesigner plantsconsumable refillsgene editingbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neoplants Comparables

Compare Neoplants with similar companies based on industry and business-model similarity.

Neoplants comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Origen Air
76%
AlgenAir
75%
Vitesy
74%

Neoplants Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 27, 2022

Key People

Founding team and executive leadership

Patrick Torbey

Co-Founder & CEO

Founding Team

Thomas Renaud

Chief Financial Officer (CFO)

Executive Team

Neoplants Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 100, 7.3x the trailing average.

  • Jul 13, 2026

    Open roles increased to 25, 83% of headcount.

Neoplants Filings

Explore SEC and related filing metadata, where available.

Neoplants filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neoplants's valuation, stock price, and market status.

Is Neoplants a public or private company?

Neoplants is a private company.

What is the current stock price of Neoplants?

Neoplants is a private company with no public stock price. No recent secondary market data is available.

How much is Neoplants worth (valuation)?

Valuation information for Neoplants is not publicly available.

Can I buy Neoplants stock?

Neoplants shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neoplants's last funding round?

Neoplants's most recent funding round was Seed on October 27, 2022.

Who are the main investors in Neoplants?

Key investors in Neoplants include Heartcore Capital.

Will Neoplants IPO soon?

No public IPO plans have been announced for Neoplants.

How can I track Neoplants secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neoplants's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range26
Year Founded2018
Last FundingOct 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?